7 results
IgM and Non-IgM - Risk and Type of Progression #EBM #Honc #MGUS #Progression #IgM #NonIgM #MultipleMyeloma
and Non-IgM - Risk ... of Progression #EBM ... #Honc #MGUS #Progression ... MultipleMyeloma #NEJM
Original and Simplified PESI Prediction Rule Test Characteristics for 30-Day Mortality
#EBM #Diagnosis	#EM #IM #PCC	#PESI #sPESI #risk
Prediction Rule Test ... Day Mortality #EBM ... #Diagnosis #EM ... #IM #PCC #PESI # ... sPESI #risk #score
Cumulative Incidence of Progression of MGUS, with Death Accounted for as a Competing Risk #EBM #Honc
as a Competing Risk ... #EBM #Honc #MGUS ... Progression #IgG #MGUS #NEJM
Rate of Survival and the Risk of Death at 90 Days, According to Subgroup #EBM #PCC
Survival and the Risk ... According to Subgroup #EBM ... #PCC #ADRENAL # ... #SepticShock #NEJM
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
4 mph walk 3. ... event, follow ACC ... determine if stress test ... Recent PCI/stenting ... since elective PCI
1,3-Beta-D-Glucan and Galactomannan Testing Sensitivity Specificity and False Positives
1,3-Beta-D-Glucan
 • Cell wall component of many fungi
Other +s: PCP, Histo ... IA PPV NPV ... the use of this test ... useful in high risk
Autoimmune Myositis - Differential Diagnosis Framework

Inflammatory Myopathies: Commonly symmetric proximal muscle weakness, no substantial muscle pain
Diagnostic Tests ... and increased risk ... • ANA < 20 % IBM ... and increased risk ... Other Diseases: • PBC